Speaker(s): 

Nicole Ortiz, MS, CGC- Genetic Counselor, Geisinger- has nothing to disclose

Jeffrey Sokoloski, MA- Product Manager, Digital Transformation, Geisinger- has nothing to disclose

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe process of initial genomic result disclosure 
• Analyze differences in contact attempts and follow-up 
• Identify unique circumstances that arise during disclosure 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Adam Buchanan, MS, MPH, LCGC, Juliann Savatt, MS, LCGC, Melissa Kelly, MS, LCGC, Marc Williams, MD, and Cara McCormick, MPH have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None